Poorly Differentiated Adenocarcinomas of Prostate Versus High-Grade Urothelial Carcinoma of the Bladder: A Diagnostic Dilemma With Immunohistochemical Evaluation of 2 Cases

Abstract

The differential diagnosis between carcinoma of the urinary bladder and adenocarcinoma of the prostate can be difficult, especially in the poorly differentiated forms infiltrating the neighboring organs. In this article, the authors report 2 cases that pose a diagnostic dilemma to the pathologist. The first is an infiltration of the bladder by a poorly differentiated adenocarcinoma of the prostate, which was clinically suspected as a papillary urothelial neoplasm. The second is a collision tumor composed of prostatic adenocarcinoma and urothelial carcinoma observed on a core needle biopsy of the prostate. In both cases, a large panel of immunohistochemical markers were used and demonstrated positivity for prostate-specific antigen and alpha methyl racemase in the prostatic carcinomas and immunoreactivity for CK7, CK20, Ag 34βE12, and p53 in the urothelial carcinoma. The differentiating histological and immunohistochemical findings are discussed.

Keywords

adenocarcinoma of prostate urothelial carcinoma collision tumor differential diagnosis

Get full access to this article

View all access options for this article.

References

Revelo MP , Cookson MS , Chang SS , Shook MF , Smith JA , Shappell SB Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004;171:646-651.

Overstreet K. , Haghighi P. Urothelial and prostate carcinoma metastasizing to the same lymph node. Arch Pathol Lab Med. 2001;125:1354-1357.

Mhawech P. , Uchida T. , Pelte MF Immunohisto chemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma. Hum Pathol. 2002;33: 1136-1140.

Nguyen PL , Schultz D. , Renshaw AA , et al. The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate. Urol Oncol . 2004;22:295-299.

Huang Q. , Chu PG , Lau SK , Weiss LM Urothelial carcinoma of the urinary bladder with a component of acinar/ tubular type differentiation simulating prostatic adenocarcinoma. Hum Pathol. 2004; 35:769-773.

Oliai B. , Kahane H. , Epstein JI A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol. 2001;25:794-801.

Genega EM , Hutchinson B. , Reuter VE , Gaudin PB Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma . Mod Pathol. 2000; 13: 1186-1191.

Mai K. , Ford JC , Morash C. , Gerridzen R. Primary and secondary prostatic adenocarcinoma of the urinary bladder. Hum Pathol. 2001;32:434-440.

Varma M. , Jasani B. Diagnostic utility of immunohisto-chemistry in morphologically difficult prostate cancer: review of current literature. Histopathology. 2005;47:1-16.

10.

Bassily N. , Vallorosi CJ , Akdas G. , Montie JE , Rubin MA Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol. 2000;113:383-388.

11.

Varma M. , Morgan M. , Amin MB , Wozniak S. , Jasani B. High molecular weight cytokeratin antibody (clone 34βE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology. 2003;42:167-172.